Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Paragon 28, Inc.

< Previous 1 2 Next >
Paragon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement System
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 To Report Second Quarter Financial Results on August 2, 2023
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Launches Phantom® Metatarsal Shortening System
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 To Report First Quarter Financial Results on May 4, 2023
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 to Present at Upcoming Investor Conferences
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28, Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 To Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28, Inc. Announces Pricing of Public Offering
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28, Inc. Announces Proposed Public Offering of Common Stock
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 to Present at The 34th Annual Piper Sandler Healthcare Conference
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 To Report Third Quarter 2022 Financial Results on November 10, 2022
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 to Present at The Morgan Stanley 20th Annual Global Healthcare Conference
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Announces Changes to its Board of Directors
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Reports Second Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 To Report Second Quarter 2022 Financial Results on August 3, 2022
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 to Present at The Canaccord Genuity 42nd Annual Growth Conference
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Launches Mobile Medical Education Lab Tour, Expanding Opportunities for Foot and Ankle Surgeon Education
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Launches TenoTac™ 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Expands Soft Tissue Portfolio with Grappler™ Suture Anchor System Launch
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Reports First Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
Paragon 28 Launches Paratrooper™ Plantar Plate System for Hammertoe and Soft Tissue Repair
From Paragon 28, Inc.
Via Business Wire
Tickers FNA
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.